New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 17, 2014
13:35 EDTOPHTOphthotech lower after company director Galakatos sells shares
Shares of Ophthotech are lower after the company's director Nicholas Galakatos disclosed in a filing, after the close last night, that he'd sold 144,976 shares of the company's stock from June 12 through June 16. Ophthotech shares are down over 4% to $42.07 in afternoon trading.
News For OPHT From The Last 14 Days
Check below for free stories on OPHT the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 16, 2014
07:32 EDTOPHTOphthotech announces Fovista Phase 2b trial presentation
Subscribe for More Information
September 9, 2014
07:55 EDTOPHTOphthotech earlier than expected Novartis payment positive, says Oppenheimer
After Ophthotech (OPHT) received a $50M Phase 3 enrollment payment from Novartis (NVS) earlier than expected, Oppenheimer thinks the payment highlights an underappreciated stock driver for Opthotech, and demonstrates that recent suggestions of Phase 3 enrollment timelines possibly slipping are unwarranted. The firm believes the company is executing well on the Fovista Phase 3 program and keeps an Outperform rating on the stock.
September 8, 2014
07:33 EDTOPHTOphthotech achieves $50M milestone under ex-agreement with Novartis for Fovista
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use